- Home
- FUTU vs HSIC Comparison
FUTU vs HSIC Comparison
Compare FUTU & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUTU
- HSIC
- Stock Information
- Founded
- FUTU 2011
- HSIC 1932
- Country
- FUTU Hong Kong
- HSIC United States
- Employees
- FUTU N/A
- HSIC N/A
- Industry
- FUTU Investment Bankers/Brokers/Service
- HSIC Medical Specialities
- Sector
- FUTU Finance
- HSIC Health Care
- Exchange
- FUTU Nasdaq
- HSIC Nasdaq
- Market Cap
- FUTU N/A
- HSIC 9.0B
- IPO Year
- FUTU 2019
- HSIC 1995
- Fundamental
- Price
- FUTU $145.92
- HSIC $70.64
- Analyst Decision
- FUTU Strong Buy
- HSIC Buy
- Analyst Count
- FUTU 4
- HSIC 10
- Target Price
- FUTU $136.23
- HSIC $78.70
- AVG Volume (30 Days)
- FUTU 2.4M
- HSIC 1.7M
- Earning Date
- FUTU 08-19-2025
- HSIC 08-05-2025
- Dividend Yield
- FUTU 1.33%
- HSIC N/A
- EPS Growth
- FUTU 58.31
- HSIC 8.11
- EPS
- FUTU 6.00
- HSIC 3.21
- Revenue
- FUTU $1,788,948,850.00
- HSIC $12,669,000,000.00
- Revenue This Year
- FUTU $48.73
- HSIC $4.28
- Revenue Next Year
- FUTU $9.97
- HSIC $3.57
- P/E Ratio
- FUTU $24.47
- HSIC $22.12
- Revenue Growth
- FUTU 54.51
- HSIC 1.75
- 52 Week Low
- FUTU $51.80
- HSIC $60.56
- 52 Week High
- FUTU $151.36
- HSIC $82.49
- Technical
- Relative Strength Index (RSI)
- FUTU 71.49
- HSIC 40.66
- Support Level
- FUTU $117.78
- HSIC $69.04
- Resistance Level
- FUTU $151.36
- HSIC $75.76
- Average True Range (ATR)
- FUTU 6.08
- HSIC 1.52
- MACD
- FUTU 2.29
- HSIC -0.39
- Stochastic Oscillator
- FUTU 83.80
- HSIC 23.81
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.